<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Osteopathic Medicine and Primary Care - Latest articles</title>
		<link>http://www.om-pc.com</link>
		<description>The latest articles from Osteopathic Medicine and Primary Care (ISSN 1750-4732) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/7"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/6"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/2/1/1"/>			    
            
				    <rdf:li rdf:resource="http://www.om-pc.com/content/1/1/14"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.om-pc.com/content/2/1/9">
            
            <title>Rediscovering the classic osteopathic literature to advance contemporary patient-oriented research: A new look at diabetes mellitus</title>
			<description>Patient care experiences represent opportunities for establishing theories, testable hypotheses, and data to assess the potential use of osteopathic manipulative treatment in various disease conditions. The re-analysis of Bandeen's 1949 raw data described herein summarizes the effects of osteopathic manipulative treatment involving pancreatic stimulatory and inhibitory techniques in diabetic and non-diabetic patients seen over a 25-year period of clinical practice. Bandeen's data demonstrate a reduction in blood glucose levels at 30 and 60 minutes following pancreatic stimulation in 150 diabetic patients, and an elevation in blood glucose levels at 30 and 60 minutes following pancreatic inhibition in 40 non-diabetic patients. Such patient-oriented research conducted during the classic era of osteopathy in the United States provides a foundation and data for generating hypotheses about the potential mechanisms of action of osteopathic manipulative treatment. Osteopathic investigators would be well-served to rediscover the classic osteopathic literature to help advance contemporary evidence-based medicine.</description>
			<link>http://www.om-pc.com/content/2/1/9</link>
			
			 	<dc:creator>John C Licciardone</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:9</dc:source>
			<dc:date>2008-07-21</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-9</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/8">
            
            <title>Osteopathy may decrease obstructive apnea in infants: a pilot study</title>
			<description>Background:
Obstructive apnea is a sleep disorder characterized by pauses in breathing during sleep: breathing is interrupted by a physical block to airflow despite effort. The purpose of this study was to test if osteopathy could influence the incidence of obstructive apnea during sleep in infants.
Methods:
Thirty-four healthy infants (age: 1.5&#8211;4.0 months) were recruited and randomized in two groups; six infants dropped out. The osteopathy treatment group (n = 15 infants) received 2 osteopathic treatments in a period of 2 weeks and a control group (n = 13 infants) received 2 non-specific treatments in the same period of time. The main outcome measure was the change in the number of obstructive apneas measured during an 8-hour polysomnographic recording before and after the two treatment sessions.
Results:
The results of the second polysomnographic recordings showed a significant decrease in the number of obstructive apneas in the osteopathy group (p = 0.01, Wilcoxon test), in comparison to the control group showing only a trend suggesting a gradual physiologic decrease of obstructive apneas. However, the difference in the decline of obstructive apneas between the groups after treatment was not significant (p = 0.43).
Conclusion:
Osteopathy may have a positive influence on the incidence of obstructive apneas during sleep in infants with a previous history of obstructive apneas as measured by polysomnography. Additional research in this area appears warranted.</description>
			<link>http://www.om-pc.com/content/2/1/8</link>
			
			 	<dc:creator>Yvan Vandenplas, Etienne Denayer, Thierry Vandenbossche, Luc Vermet, Bruno Hauser, Jean DeSchepper and Agnes Engelen</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:8</dc:source>
			<dc:date>2008-07-19</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-8</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/7">
            
            <title>Osteopathic manipulative treatment and its relationship to autonomic nervous system activity as demonstrated by heart rate variability: a repeated measures study</title>
			<description>Background:
The relationship between osteopathic manipulative treatment (OMT) and the autonomic nervous system has long been acknowledged, but is poorly understood. In an effort to define this relationship, cervical myofascial release was used as the OMT technique with heart rate variability (HRV) as a surrogate for autonomic activity. This study quantifies that relationship and demonstrates a cause and effect.
Methods:
Seventeen healthy subjects, nine males and eight females aged 19&#8211;50 years from the faculty, staff, and students at Oklahoma State University Center for Health Sciences College of Osteopathic Medicine, acted as their own controls and received interventions, administered in separate sessions at least 24 hours apart, of cervical myofascial OMT, touch-only sham OMT, and no-touch control while at a 50-degree head-up tilt. Each group was dichotomized into extremes of autonomic activity using a tilt table. Comparisons were made between measurements taken at tilt and those taken at pre- and post-intervention in the horizontal.The variance of the spectral components of HRV, expressed as frequencies, measured the response to change in position of the subjects. Normalized low frequency (LF) and high frequency (HF) values, including LF/HF ratio, were calculated and used to determine the effect of position change on HRV.
Results:
Predominantly parasympathetic responses were observed with subjects in the horizontal position, while a 50-degree tilt provided a significantly different measure of maximum sympathetic tone (p &lt; 0.001). Heart rate changed in all subjects with change in position; respirations remained constant. When OMT was performed in a sympathetic environment (tilt), a vagal response was produced that was strong enough to overcome the sympathetic tone. There was no HRV difference between sham and control in either the horizontal or tilt positions.
Conclusion:
The vagal response produced by the myofascial release procedure in the maximally stimulated sympathetic environment could only have come from the application of the OMT. This demonstrates the association between OMT and the autonomic nervous system. The lack of significance between control and sham in all positions indicates that HRV may be a useful method of developing sham controls in future studies of OMT.Trial registrationclinicaltrials.gov NCT00516984.</description>
			<link>http://www.om-pc.com/content/2/1/7</link>
			
			 	<dc:creator>Charles E Henley, Douglas Ivins, Miriam Mills, Frances K Wen and Bruce A Benjamin</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:7</dc:source>
			<dc:date>2008-06-05</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-7</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/6">
            
            <title>The somatically preoccupied patient in primary care: use of attachment theory to strengthen physician-patient relationships</title>
			<description>Background:
Individuals with somatic preoccupation constitute a substantial number of primary care patients. Somatically preoccupied patients are challenging to primary care physicians for several reasons including patient complaints consuming a great deal of physician time, expense to diagnose and treat and strain on the physician-patient relationship. This paper examines and discusses how disruptions in early attachment relationships such as often occurs when a female is a victim of child sexual abuse may result in somatic preoccupation in adulthood.Treatment utilizing attachment theoryAttachment theory provides a useful framework for primary care physicians to conceptualize somatic preoccupation. Utilization and containment techniques grounded in an understanding of attachment dynamics aid the physician in developing a sound physician-patient relationship. Successfully engaging the patient in treatment prevents misunderstandings that frequently derail medical care for somatically preoccupied patients.</description>
			<link>http://www.om-pc.com/content/2/1/6</link>
			
			 	<dc:creator>Robert C Miller</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:6</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-6</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/5">
            
            <title>OSTEOPAThic Health outcomes In Chronic low back pain: The OSTEOPATHIC Trial</title>
			<description>Background:
Osteopathic manipulative treatment (OMT) and ultrasound physical therapy (UPT) are commonly used for chronic low back pain. Although there is evidence from a systematic review and meta-analysis that OMT generally reduces low back pain, there are no large clinical trials that specifically assess OMT efficacy in chronic low back pain. Similarly, there is a lack of evidence involving UPT for chronic low back pain.
Methods:
The OSTEOPAThic Health outcomes In Chronic low back pain (OSTEOPATHIC) Trial is a Phase III randomized controlled trial that seeks to study 488 subjects between August 2006 and June 2010. It uses a 2 &#215; 2 factorial design to independently assess the efficacy of OMT and UPT for chronic low back pain. The primary outcome is a visual analogue scale score for pain. Secondary outcomes include back-specific functioning, generic health, work disability, and satisfaction with back care.
Conclusion:
This randomized controlled trial will potentially be the largest involving OMT. It will provide long awaited data on the efficacy of OMT and UPT for chronic low back pain.Trial registrationhttp://www.clinicaltrials.gov, NCT00315120</description>
			<link>http://www.om-pc.com/content/2/1/5</link>
			
			 	<dc:creator>John C Licciardone, Hollis H King, Kendi L Hensel and Daniel G Williams</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:5</dc:source>
			<dc:date>2008-04-25</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-5</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/4">
            
            <title>Common crossroads in diabetes management</title>
			<description>The prevalence and impact of type 2 diabetes are reaching epidemic proportions in the United States. Data suggest that effective management can reduce the risk for both microvascular and macrovascular complications of diabetes. In treating patients with diabetes, physicians must be prepared not only to tailor the initial treatment to the individual and his or her disease severity but also to advance treatment as necessary and in step with disease progression.The majority of patients with diabetes are not at goal for glycated hemoglobin A1C, fasting plasma glucose, or postprandial plasma glucose levels. Although lifestyle changes based on improved diet and exercise practices are basic elements of therapy at every stage, pharmacologic therapy is usually necessary to achieve and maintain glycemic control. Oral antidiabetic agents may be effective early in the disease but, eventually, they are unable to compensate as the disease progresses. For patients unable to achieve glycemic control on 2 oral agents, current guidelines strongly urge clinicians to consider the initiation of insulin as opposed to adding a third oral agent. Recent research suggests that earlier initiation of insulin is more physiologic and may be more effective in preventing complications of diabetes. Newer, longer-lasting insulin analogs and the use of simplified treatment plans may overcome psychological resistance to insulin on the part of physicians and patients.This article summarizes the risks associated with uncontrolled fasting and postprandial hyperglycemia, briefly reviews the various treatment options currently available for type 2 diabetes, presents case vignettes to illustrate crossroads encountered when advancing treatment, and offers guidance to the osteopathic physician on the selection of appropriate treatments for the management of type 2 diabetes.</description>
			<link>http://www.om-pc.com/content/2/1/4</link>
			
			 	<dc:creator>Michael Valitutto</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:4</dc:source>
			<dc:date>2008-02-15</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-4</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/3">
            
            <title>Psychopathology and functional impairment among patients attending an adolescent health clinic: Implications for healthcare model reform</title>
			<description>Background:
In developing countries, primary health care facilities, such as adolescent health clinics, are frequently the first contact for an adolescent with a health professional for a myriad of health problems including mental health issues. Psychopathology is prevalent among adolescents, and causes significant educational, occupational and social impairment. The presence of psychopathology with impairment requires the development of treatment models to address both of these components. We studied the psychopathology and associated impairment in patients at an adolescent health clinic as an indicator for healthcare model reform.
Methods:
Psychopathology and functional impairment were assessed in 100 patients at an adolescent health clinic in the city of Chennai, Southern India. The patients had initially visited the clinic for various medical disorders. Adolescents were diagnostically classified for psychopathology using the Child Behaviour Checklist (CBCL) and the International Classification of Disease: 10th Edition (ICD-10). Functional impairment was assessed with the Child Global Assessment Scale (CGAS). Data were analysed using bivariate and multivariate methods.
Results:
Eight percent had a diagnosable psychopathology, and they also satisfied at least one ICD-10 diagnosis. Adolescents screened had significant impairment as indicated by low CGAS scores, whether or not they presented with psychopathology. Adolescents with psychopathology were more functionally impaired both in the bivariate (Z = -3.1; P = 0.002) and multivariate analyses (&#946;(SE) = 1.09(0.3), t = 3.9, 95% confidence interval = 0.5, 1.6; P = 0.001). Impairment in adolescents without psychopathology is primarily attributed to the medical disorders they presented with.
Conclusion:
Patients attending adolescent health clinics should be screened for psychopathology and functional impairment. Documented psychopathology and impairment necessitates the use of a combined treatment model to address the short and long-term problems these adolescents face.</description>
			<link>http://www.om-pc.com/content/2/1/3</link>
			
			 	<dc:creator>Sushila Russell, Balakrishnan Subramanian and Paul Swamidhas Sudhakar Russell</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:3</dc:source>
			<dc:date>2008-02-08</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-3</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/2">
            
            <title>OTC analgesics and drug interactions: clinical implications</title>
			<description>The risk of drug interactions with concurrent use of multiple medications is a clinically relevant issue. Many patients are unaware that over-the-counter (OTC) analgesics can cause potentially serious adverse effects when used in combination with other common medications such as anticoagulants, corticosteroids, or antihypertensive agents. Of particular significance is the increased risk of upper abdominal gastrointestinal adverse events in patients who take traditional nonsteroidal anti-inflammatory drugs (NSAIDs). This risk is dose dependent and further increased in patients who take more than one NSAID or use NSAIDs in combination with certain other medications. Some NSAIDs may also mitigate the antiplatelet benefits of aspirin and may increase blood pressure in patients with hypertension. Clinicians should be aware of potential drug interactions with OTC analgesics when prescribing new medications. Additionally, patients should be properly counseled on the appropriate and safe use of OTC analgesics.</description>
			<link>http://www.om-pc.com/content/2/1/2</link>
			
			 	<dc:creator>A Mark Fendrick, Deborah E Pan and Grace E Johnson</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:2</dc:source>
			<dc:date>2008-02-07</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-2</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/2/1/1">
            
            <title>Osteopathic Medicine and Primary Care completes first year of publication</title>
			<description>Osteopathic Medicine and Primary Care affords authors the opportunity for rapid and universal dissemination of their work. We are keen to receive author manuscripts and reader comments on articles during 2008. A journal fund has been established to offset the cost of article processing charges for eligible authors who submit qualified manuscripts.</description>
			<link>http://www.om-pc.com/content/2/1/1</link>
			
			 	<dc:creator>John C Licciardone and Roberto Cardarelli</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2008, 2:1</dc:source>
			<dc:date>2008-01-24</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-2-1</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.om-pc.com/content/1/1/14">
            
            <title>Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations</title>
			<description>Anemia is an underrecognized but characteristic feature of chronic kidney disease (CKD), associated with significant cardiovascular morbidity, hospitalization, and mortality. Since their inception nearly two decades ago, erythropoiesis-stimulating agents (ESAs) have revolutionized the care of patients with renal anemia, and their use has been associated with improved quality of life and reduced hospitalizations, inpatient costs, and mortality. Hemoglobin targets &#8805;13 g/dL have been linked with adverse events in recent randomized trials, raising concerns over the proper hemoglobin range for ESA treatment. This review appraises observational and randomized studies of the outcomes of erythropoietic treatment and offers recommendations for managing renal anemia in the primary care setting.</description>
			<link>http://www.om-pc.com/content/1/1/14</link>
			
			 	<dc:creator>Rebecca J Schmidt and Cheryl L Dalton</dc:creator>
			
			<dc:source>Osteopathic Medicine and Primary Care 2007, 1:14</dc:source>
			<dc:date>2007-10-02</dc:date>
			<dc:identifier>doi:10.1186/1750-4732-1-14</dc:identifier>
			
			
							
					<prism:publicationName>Osteopathic Medicine and Primary Care</prism:publicationName>
					
			
							
					<prism:issn>1750-4732</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
